Saturday, June 15, 2024

Second Round of New Medical Technology Evaluation Guidance Service for 2024

Similar articles

The report, prepared by the Korea Institute of Health and Medical Research (Bo Eui-yeon), announces the commencement of the recruitment process for the 2nd ‘New Medical Technology Evaluation Guidance Service’ from May 13 to May 24. The service, offered by the Korea Institute of Health and Medical Services, aims to assist medical device development companies, medical institutions, and research institutes in the early adoption of safe and excellent medical technologies. Tailored advisory services are provided to support the full cycle of medical technology development, free of charge.

Priority targets for support include domestic medical technologies in the development stage, those with public interest and social value, and innovative and cutting-edge medical technologies. Approximately 15 technologies will be selected each quarter, with advisory services offered for up to six months.

The application process for the 2nd ‘New Medical Technology Evaluation Guidance Service’ offers interested parties the opportunity to submit their applications conveniently through the dedicated New Medical Technology Evaluation Project Headquarters website. This online platform streamlines the application process, making it accessible to a wide range of medical device development companies, medical institutions, and research institutes. By providing a user-friendly interface and clear instructions, the website ensures that applicants can navigate the submission process with ease.

Medical Technology Guidance Service Application Deadline Approaches

Applicants are encouraged to take advantage of this opportunity by submitting their applications before the deadline on May 24. This deadline allows sufficient time for interested parties to gather the necessary documentation and information required for their applications. Once the application period has closed, the review process will commence, with careful consideration given to each submission.

Following the review process, applicants will be individually notified of their selection status on June 10. This personalized approach ensures transparency and fairness in the selection process, allowing applicants to receive timely feedback on their applications. For those selected to participate in the guidance service, consultation schedules will be confirmed accordingly, taking into account the availability and preferences of both the applicants and the consulting experts.

The consultation schedules will be tailored to accommodate the specific needs and objectives of each participating entity. Whether it’s discussing the evaluation of new medical technologies, conducting literature searches, or providing advice on clinical trial protocols, the consultation sessions will be designed to address the unique challenges and opportunities faced by the participants. Additionally, the consultation schedules will allow for ongoing communication and collaboration between the participants and the Korea Institute of Health and Medical Services, fostering a supportive and collaborative environment throughout the guidance service.

Medical Technology

Korea Institute Offers Streamlined Application Process for New Medical Technology Evaluation Guidance

Overall, the application process for the 2nd ‘New Medical Technology Evaluation Guidance Service’ provides a streamlined and transparent pathway for interested parties to access valuable support and resources for the evaluation of new medical technologies. By leveraging the online application platform and personalized consultation schedules, the Korea Institute of Health and Medical Services aims to empower medical device developers, institutions, and research institutes to advance the adoption of safe and innovative medical technologies in the healthcare industry.

Selected applicants will receive comprehensive advice on new medical technology evaluation, literature search support services, and other guidance provided by the Korea Institute of Health and Medical Services, all free of charge. Additionally, advice on clinical trial protocols can be obtained using the expertise of the New Medical Technology Evaluation Committee.

You can follow our news on our Telegram and LinkedIn accounts.

Korea Institute Enhances Global Healthcare Market Entry with Targeted MDR Education

In the first half of the year, lectures will be conducted on topics such as MDR education for entering overseas markets, catering to the demand for education on desired topics. Non-face-to-face courses, including the Korean Open Online Course (K-MOOC), will be offered to foster domestic healthcare researchers.

Testimonials from companies that have benefited from the guidance service highlight its effectiveness in providing comprehensive consultation and expert advice, ultimately aiding in product development and commercialization. Director Lee Jae-tae emphasizes the satisfaction among applicants and the service’s accessibility to companies regardless of their location, with a focus on supporting evidence creation for overseas market entry.

Looking ahead, the Korea Institute of Health and Medical Services aims to enhance support for evidence creation and assist domestic companies in utilizing medical technology evaluation reports for overseas certification when entering global markets.

 

Resource: National Evidence-based Healthcare Collaborating Agency, May 14, 2024

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article